Intelligent Investor

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $32.910 0.05 (0.15%)

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$20,431 Notice of Annual General Meeting/Proxy Form 6 Oct 2023 8:20AM $23.280 $32.910 $31.500 risen by 41.37%
$20,431 Statement of CDIs on issue - RMD 4 Oct 2023 1:17PM $22.940 $32.910 $31.500 risen by 43.46%
$20,431 Statement of CDIs on issue - RMD 6 Sep 2023 11:44AM $23.760 $32.910 $31.500 risen by 38.51%
$20,431 Update - Dividend/Distribution - RMD 21 Aug 2023 5:27PM $26.080 $32.910 $31.500 risen by 26.19%
$20,431 ResMed Form 10-k Annual Report 14 Aug 2023 9:41AM $27.470 $32.910 $31.500 risen by 19.80%
$20,431 Dividend/Distribution - RMD 4 Aug 2023 8:20AM $33.850 $32.910 $31.500 fallen by 2.78%
$20,431 ResMed Announces Results for the Fourth Quarter of FY2023 4 Aug 2023 8:20AM $33.850 $32.910 $31.500 fallen by 2.78%
$20,431 Statement of CDIs on issue - RMD 3 Aug 2023 8:18AM $33.990 $32.910 $31.500 fallen by 3.18%
$20,431 RMD to Report Fourth Quarter Fiscal 2023 Results 7 Jul 2023 8:20AM $32.320 $32.910 $31.500 risen by 1.83%
$20,431 Statement of CDIs on issue - RMD 6 Jul 2023 12:30PM $32.350 $32.910 $31.500 risen by 1.73%
$20,431 Statement of CDIs on issue - RMD 6 Jun 2023 8:52AM $33.250 $32.910 $31.500 fallen by 1.02%
$20,431 FORM SD 29 May 2023 8:18AM $33.310 $32.910 $31.500 fallen by 1.20%
$20,431 Update - Dividend/Distribution - RMD 15 May 2023 10:11AM $34.880 $32.910 $31.500 fallen by 5.65%
$20,431 Statement of CDIs on issue - RMD 4 May 2023 9:59AM $35.330 $32.910 $31.500 fallen by 6.85%
$20,431 FORM 10Q for Qtr ended March, 2023 1 May 2023 9:40AM $33.710 $32.910 $31.500 fallen by 2.37%
$20,431 Dividend/Distribution - RMD 28 Apr 2023 8:15AM $33.730 $32.910 $31.500 fallen by 2.43%
$20,431 ResMed Announces Results for the Third Quarter of FY2023 28 Apr 2023 8:15AM $33.730 $32.910 $31.500 fallen by 2.43%
$20,431 RMD to Report Third Quarter Fiscal 2023 Results 11 Apr 2023 8:15AM $33.130 $32.910 $31.500 fallen by 0.66%
$20,431 Statement of CDIs on issue - RMD 4 Apr 2023 12:50PM $32.450 $32.910 $31.500 risen by 1.42%
$20,431 Company Secretary Appointment/Resignation 31 Mar 2023 8:20AM $32.180 $32.910 $31.500 risen by 2.27%
$20,431 Statement of CDIs on issue - RMD 3 Mar 2023 11:33AM $31.820 $32.910 $31.500 risen by 3.43%
$20,431 Update - Dividend/Distribution - RMD 10 Feb 2023 1:00PM $31.050 $32.910 $31.500 risen by 5.99%
$20,431 Statement of CDIs on issue - RMD 3 Feb 2023 9:35AM $32.000 $32.910 $31.500 risen by 2.84%
$20,431 FORM 10Q for Qtr ended December, 2022 30 Jan 2023 8:51AM $33.650 $32.910 $31.500 fallen by 2.20%
$20,431 Dividend/Distribution - RMD 27 Jan 2023 8:39AM $32.960 $32.910 $31.500 fallen by 0.15%

26 - 50 of 426 results

Page 2 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.